A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Benzethidine
Caroxazone
The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Nafamostat.
Benzethidine
Safrazine
The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Nafamostat.
Benzethidine
Pivhydrazine
The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Nafamostat.
Benzethidine
Phenoxypropazine
The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Nafamostat.
Benzethidine
Pheniprazine
The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Nafamostat.
Benzethidine
Octamoxin
The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Nafamostat.
Benzethidine
Mebanazine
The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Nafamostat.
Benzethidine
Benmoxin
The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Nafamostat.
Benzethidine
Toloxatone
The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Nafamostat.
Benzethidine
Pirlindole
The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Nafamostat.
Benzethidine
Hydracarbazine
The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Nafamostat.
Benzethidine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Nafamostat.
Benzethidine
Nialamide
The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Nafamostat.
Benzethidine
Iproniazid
The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Nafamostat.
Benzethidine
Clorgiline
The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Nafamostat.
Benzethidine
Pargyline
The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Nafamostat.
Benzethidine
Estradiol dienanthate
The serum concentration of Nafamostat can be increased when it is combined with Estradiol dienanthate.
Benzethidine
Enasidenib
The serum concentration of Nafamostat can be increased when it is combined with Enasidenib.
Benzethidine
Dexchlorpheniramine maleate
The serum concentration of Nafamostat can be increased when it is combined with Dexchlorpheniramine maleate.
Benzethidine
D-Levofloxacin
The serum concentration of Nafamostat can be increased when it is combined with D-Levofloxacin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3